Sealand Capital Galaxy Limited Issue of Equity

RNS Number : 1310B

Sealand Capital Galaxy Limited

29 January 2024

 

For immediate release

 

Sealand Capital Galaxy Limited

("Sealand" or the "Company")

 

Issue of Equity

 

Sealand Capital Galaxy Limited (LSE: SCGL) announces that it has agreed the allotment and issue of 9,090,909 ordinary shares of £0.0001 each in the capital of the Company to Novum Securities Limited, in consideration for professional services provided. 

 

Application will be made for the 9,090,909 new ordinary shares to be admitted to trading which is expected to be on or around Thursday 1 February 2024.

 

The new ordinary shares will rank pari passu with the existing ordinary shares of the Company. Following the issue of the new ordinary shares, the Company's issued share capital will comprise of 724,905,989 ordinary shares. This figure of 724,905,989 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulation (EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of the European Union (Withdrawal) Act 2018 (as amended).

 

-Ends-

 

Enquiries:
Sealand Capital Galaxy Limited
Law Chung Lam Nelson, Executive Chairman	+ 44 (0) 753 795 9788
Novum Securities Limited
David Coffman	Tel: [phone]

 

Notes to Editors:

 

The Company's Shares are traded on the Official List of the London Stock Exchange's main market for listed securities under the ticker SCGL.

 

Further information on Sealand is available on its website  http://www.scg-ltd.com/ 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

IOEBPMATMTJTBRI